199 related articles for article (PubMed ID: 20442283)
1. Estrogen-dependent and estrogen-independent mechanisms contribute to AIB1-mediated tumor formation.
Torres-Arzayus MI; Zhao J; Bronson R; Brown M
Cancer Res; 2010 May; 70(10):4102-11. PubMed ID: 20442283
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice.
Tilli MT; Reiter R; Oh AS; Henke RT; McDonnell K; Gallicano GI; Furth PA; Riegel AT
Mol Endocrinol; 2005 Mar; 19(3):644-56. PubMed ID: 15550471
[TBL] [Abstract][Full Text] [Related]
3. Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial content.
Nakles RE; Shiffert MT; Díaz-Cruz ES; Cabrera MC; Alotaiby M; Miermont AM; Riegel AT; Furth PA
Mol Endocrinol; 2011 Apr; 25(4):549-63. PubMed ID: 21292825
[TBL] [Abstract][Full Text] [Related]
4. Targeting the AIB1 oncogene through mammalian target of rapamycin inhibition in the mammary gland.
Torres-Arzayus MI; Yuan J; DellaGatta JL; Lane H; Kung AL; Brown M
Cancer Res; 2006 Dec; 66(23):11381-8. PubMed ID: 17145884
[TBL] [Abstract][Full Text] [Related]
5. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
6. The nuclear coactivator amplified in breast cancer 1 maintains tumor-initiating cells during development of ductal carcinoma in situ.
Ory V; Tassi E; Cavalli LR; Sharif GM; Saenz F; Baker T; Schmidt MO; Mueller SC; Furth PA; Wellstein A; Riegel AT
Oncogene; 2014 Jun; 33(23):3033-42. PubMed ID: 23851504
[TBL] [Abstract][Full Text] [Related]
7. AIB1/SRC-3 deficiency affects insulin-like growth factor I signaling pathway and suppresses v-Ha-ras-induced breast cancer initiation and progression in mice.
Kuang SQ; Liao L; Zhang H; Lee AV; O'Malley BW; Xu J
Cancer Res; 2004 Mar; 64(5):1875-85. PubMed ID: 14996752
[TBL] [Abstract][Full Text] [Related]
8. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
[TBL] [Abstract][Full Text] [Related]
9. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
[TBL] [Abstract][Full Text] [Related]
10. Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions.
Mercier I; Casimiro MC; Zhou J; Wang C; Plymire C; Bryant KG; Daumer KM; Sotgia F; Bonuccelli G; Witkiewicz AK; Lin J; Tran TH; Milliman J; Frank PG; Jasmin JF; Rui H; Pestell RG; Lisanti MP
Am J Pathol; 2009 Apr; 174(4):1172-90. PubMed ID: 19342371
[TBL] [Abstract][Full Text] [Related]
11. Alcohol promotes mammary tumor development via the estrogen pathway in estrogen receptor alpha-negative HER2/neu mice.
Wong AW; Dunlap SM; Holcomb VB; Nunez NP
Alcohol Clin Exp Res; 2012 Apr; 36(4):577-87. PubMed ID: 21981381
[TBL] [Abstract][Full Text] [Related]
12. High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene.
Torres-Arzayus MI; Font de Mora J; Yuan J; Vazquez F; Bronson R; Rue M; Sellers WR; Brown M
Cancer Cell; 2004 Sep; 6(3):263-74. PubMed ID: 15380517
[TBL] [Abstract][Full Text] [Related]
13. Growth and characterization of N-methyl-N-nitrosourea-induced mammary tumors in intact and ovariectomized rats.
Thordarson G; Lee AV; McCarty M; Van Horn K; Chu O; Chou YC; Yang J; Guzman RC; Nandi S; Talamantes F
Carcinogenesis; 2001 Dec; 22(12):2039-47. PubMed ID: 11751437
[TBL] [Abstract][Full Text] [Related]
14. Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression.
Yoshidome K; Shibata MA; Couldrey C; Korach KS; Green JE
Cancer Res; 2000 Dec; 60(24):6901-10. PubMed ID: 11156389
[TBL] [Abstract][Full Text] [Related]
15. A hypersensitive estrogen receptor alpha mutation that alters dynamic protein interactions.
Herynk MH; Hopp T; Cui Y; Niu A; Corona-Rodriguez A; Fuqua SA
Breast Cancer Res Treat; 2010 Jul; 122(2):381-93. PubMed ID: 19842032
[TBL] [Abstract][Full Text] [Related]
16. Hormone dependence in premalignant mammary progression.
Medina D; Kittrell FS; Shepard A; Contreras A; Rosen JM; Lydon J
Cancer Res; 2003 Mar; 63(5):1067-72. PubMed ID: 12615724
[TBL] [Abstract][Full Text] [Related]
17. Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cells.
List HJ; Lauritsen KJ; Reiter R; Powers C; Wellstein A; Riegel AT
J Biol Chem; 2001 Jun; 276(26):23763-8. PubMed ID: 11328819
[TBL] [Abstract][Full Text] [Related]
18. Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis.
Kuang SQ; Liao L; Wang S; Medina D; O'Malley BW; Xu J
Cancer Res; 2005 Sep; 65(17):7993-8002. PubMed ID: 16140972
[TBL] [Abstract][Full Text] [Related]
19. Capacity of adipose tissue to promote growth and metastasis of a murine mammary carcinoma: effect of estrogen and progesterone.
Elliott BE; Tam SP; Dexter D; Chen ZQ
Int J Cancer; 1992 May; 51(3):416-24. PubMed ID: 1317363
[TBL] [Abstract][Full Text] [Related]
20. Development of a novel molecular sensor for imaging estrogen receptor-coactivator protein-protein interactions.
Lake MC; Nguyen QD; Ali S; Aboagye EO
PLoS One; 2012; 7(8):e44160. PubMed ID: 22952913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]